A lot of healthcare technology leaders are in the same place right now. The EHR rollout happened years ago, interfaces exist, and data does move between systems. But when you try to launch a population health program, support a merger, stand up patient-facing apps, or feed a Snowflake analytics environment with clean longitudinal data, the cracks show fast.
One feed arrives late. Another carries the right patient but the wrong coding context. Clinical notes are visible, yet hard to operationalize. The organization is technically connected, but not operationally aligned.
That gap is what makes interoperable electronic health records a board-level issue. The business case isn't just compliance or better interfaces. It's whether your organization can turn fragmented clinical data into safer care, faster operations, stronger patient access, and a usable data foundation for analytics, automation, and AI.
Why Interoperability Is a Strategic Imperative Now
For many CTOs, interoperability becomes urgent when the organization changes shape. A newly acquired clinic uses a different EHR. A value-based contract demands better care coordination. A service line leader wants enterprise analytics, but the source data is inconsistent across hospitals, ambulatory sites, labs, and patient apps.
At that point, interoperability stops being a middleware problem. It becomes a growth, risk, and operating model problem.
The market has already moved. By 2023, 70% of non-federal acute care hospitals were routinely engaged in all four interoperability domains, find, send, receive, and integrate, up from 46% in 2018, according to the ONC Health IT data brief on interoperable exchange among U.S. hospitals. That matters because hospitals are no longer treating interoperable exchange as a side project. It is becoming part of the baseline expectation for modern operations.
What changes when interoperability becomes strategic
When data moves reliably across care settings, leaders can support decisions that are difficult or expensive with siloed systems:
- Clinical coordination improves: Care teams can work from a broader record instead of rebuilding history through calls, faxes, and repeated intake.
- Operating friction drops: Staff spend less time reconciling disconnected systems and more time on exception handling.
- Patient access gets stronger: Consumer-style digital services depend on data portability, not just portal access.
- Analytics become credible: Enterprise reporting, quality programs, and AI projects fail when source data can't be trusted across systems.
Practical rule: If an interoperability initiative can't be tied to a care, cost, access, or analytics outcome, it's probably scoped too narrowly.
This is also where strategy needs a broader lens than interface counts. A leadership team should ask whether the program supports future-state capabilities such as patient-directed data sharing, cross-entity care management, and secondary use of clinical data in modern platforms. Teams evaluating options often benefit from a framework that connects technical architecture with operating outcomes, such as these healthcare interoperability solutions.
Compliance is the floor, not the goal
Most organizations begin with regulatory pressure, partner requirements, or patient access mandates. That's understandable. It gets budget approved.
But the organizations that create durable value treat interoperable electronic health records as infrastructure. The same pipes that support summary-of-care exchange can also support longitudinal patient records, quality measurement, care gap detection, denials analysis, and governed analytics in Snowflake. The technical work is similar. The difference is whether leadership designs for reuse from the start.
The Three Levels of EHR Interoperability Explained
Most interoperability programs fail in one predictable way. The project team proves that data can move, then executives assume the hard part is done. It usually isn't.
Interoperable electronic health records are typically described across three layers: foundational interoperability, structural interoperability, and semantic interoperability, as explained in the HIPAA Journal overview of EHR interoperability.
A simple way to explain the difference is to think about translating a clinical document between two teams that speak different technical languages.
Foundational means the pipe works
At the foundational level, one system can send data and another can receive it. This is basic connectivity.
That's necessary, but it only answers one question. Can the message get there?
A lot of legacy interface work stops here. Messages flow. Delivery is logged. The integration engine looks healthy. Yet clinicians may still have to open a document manually, search for the relevant fact, and re-enter it into a local workflow.
Structural means the format survives the trip
At the structural level, the receiving system preserves the organization of the data. A medication remains a medication. A lab result still includes expected fields. Dates, units, identifiers, and sections land in recognizable places.
Standards and mapping discipline are essential. Structural interoperability is what lets downstream systems parse data consistently instead of treating everything like a blob of text or a flat file export.
A short explainer helps when you need to align technical and clinical stakeholders:
Semantic means the data is usable without guesswork
The hard part is semantic interoperability. That's when the receiving system can use the data without manual reinterpretation.
If one system records a diagnosis, problem status, observation, or medication concept, the other system has to understand what that item means in clinical context. Not approximately. Correctly enough to support care, reporting, and automation.
Data exchange is a transport problem. Semantic interoperability is a trust problem.
For a CTO, this distinction is critical when evaluating vendor claims. A vendor may say it supports FHIR, HL7, or API-based exchange. That tells you something about transport and structure. It does not prove the data will be reliable for medication reconciliation, decision support, quality measures, or Snowflake-based analytics.
A good executive test is simple:
- Can we connect? Foundational.
- Can we parse what we received? Structural.
- Can we use it safely and consistently in workflows and analytics? Semantic.
Only the third level creates durable enterprise value.
Key Standards and Modern Integration Architectures
Standards matter, but leaders don't need a protocol lecture. They need to know which standards fit which business outcomes.
In practice, most health systems operate in a mixed environment. Legacy messaging still runs core operational workflows. Document-based exchange still appears in many transitions of care. Modern APIs are expanding patient access and app ecosystems. Analytics teams often need a separate pattern altogether, because what works for a real-time clinician workflow doesn't automatically work for enterprise data engineering.
What each standard is good at
The standards conversation usually centers on HL7 v2, CDA, and FHIR. They each serve a purpose.
StandardPrimary Use CaseData ModelKey AdvantageHL7 v2Event-based clinical and operational messaging between systemsMessage segmentsMature and deeply embedded in hospital operationsCDADocument exchange such as summaries of careStructured clinical documentsGood for packaging multi-part clinical contextFHIRAPI-driven exchange for apps, services, and modern integrationsModular resourcesBetter fit for modern application development and patient-directed access
HL7 v2 remains common for admissions, discharges, orders, results, and other transactional workflows. CDA can still be useful when you need to exchange a richer clinical document. FHIR changes the model by making healthcare data more accessible through resource-based APIs that fit modern software development patterns.
Match architecture to the use case
A common mistake is trying to use one integration style for every need. That creates either brittle real-time systems or analytics pipelines that arrive too late.
Use cases tend to split into three patterns:
- Real-time API access: Best for clinician and patient workflows where the application needs data on demand, such as medications, allergies, appointments, or notes.
- Event-driven integration: Useful when systems need to react to changes, such as admissions, discharges, or new observations.
- Data pipelines for analytics: Best for longitudinal storage, normalization, quality checks, and downstream analytics in a data platform.
For Snowflake-oriented architectures, the key question isn't whether data can be exported. It's whether clinical events, resources, and reference data can be ingested with enough provenance and consistency to support governed analytics later. That often means separating transactional interoperability from analytical interoperability. The first serves the moment of care. The second serves enterprise insight.
Why this matters for Snowflake
FHIR resources are especially attractive for modern data platforms because they can be ingested as structured or semi-structured data, then normalized for analytics, care management, and automation. A CTO should still be careful here. API access does not remove the need for identity resolution, terminology mapping, encounter logic, and stewardship.
A useful example of how Snowflake can support large operational environments appears in this EMS utilization on Snowflake success story. The healthcare lesson is broader than one implementation. Once data lands in a scalable platform with strong governance, organizations can support analytics, automation, and operational visibility without building every report directly inside the EHR.
Navigating Security Privacy and Patient Consent
Interoperability only works if patients, clinicians, and regulators trust the exchange model. That trust isn't created by a policy memo. It comes from secure implementation, clear consent handling, and auditability that holds up under scrutiny.
The policy environment pushed this forward. The 21st Century Cures Act shifted the market toward broader interoperability and anti-information-blocking expectations. Patient access is a major part of that shift. By 2024, 81% of U.S. hospitals enabled patient access via apps, and 70% were using FHIR-based apps, as summarized in the PaceMate interoperability statistics article. That's a strong signal that API-based, patient-directed sharing is no longer niche.
Security design has to match the access model
Once organizations expose data through APIs, the security model has to evolve with it. Traditional perimeter thinking isn't enough when third-party apps, mobile access, and partner ecosystems enter the picture.
A practical architecture usually includes:
- Strong authorization controls: OAuth 2.0 and SMART on FHIR are widely used patterns for managing app access and delegated authorization.
- Scoped access decisions: Teams should limit what each app, user, or service can read or write.
- Audit trails: Every access event should be traceable to who requested it, when it happened, and what data moved.
- Consent-aware workflows: Sensitive use cases need policy-aligned rules for when data can be shared, withheld, or segmented.
Consent is operational, not just legal
Many organizations treat consent as a compliance checklist managed by legal and privacy teams. In practice, consent affects architecture, UI, support processes, and data governance.
If patients can authorize apps to access records, your teams need to answer operational questions fast. How is consent captured? How is revocation handled? How do downstream systems know the current sharing status? Which datasets require extra handling? What happens when patient expectations and legacy workflows collide?
A weak consent model doesn't just create compliance risk. It creates support tickets, clinician confusion, and mistrust in the data-sharing program.
Healthcare organizations operating across jurisdictions or dealing with stricter privacy expectations often benefit from formal privacy review methods before rollout. For teams that need a concrete governance reference, this overview of a privacy impact assessment Alberta process is useful because it shows how privacy review can be structured before systems go live.
Building Governance for High-Quality Interoperable Data
A lot of interoperability projects succeed on paper and fail in analytics. Interfaces are active, transactions are logged, and dashboards still produce arguments in governance meetings because nobody fully trusts the underlying meaning of the data.
That's the point where leaders discover that transport standards didn't solve semantic consistency.
A 2024 systematic review found only 14 studies on semantic interoperability of EHRs, highlighting how little attention the industry has given to preserving clinical meaning across systems, according to the JMIR Medical Informatics review on semantic interoperability. For CTOs building data platforms, that gap matters more than it first appears. If meanings drift, every downstream use case becomes more expensive.
Why standards alone don't create trustworthy data
Two systems can both claim FHIR support and still disagree in ways that break reporting and automation. A field may be present but coded differently. A medication may arrive without the context needed for reconciliation. A diagnosis may be represented with local conventions that don't align cleanly to enterprise analytics logic.
That's why governance has to sit above integration.
A strong program usually includes:
- Data stewardship: Named owners for critical domains such as patient, provider, encounter, medication, lab, and payer data.
- Terminology management: Controlled mappings across code systems and local variants.
- Master data discipline: Patient and provider identity processes that reduce duplication and ambiguity.
- Provenance and lineage: Clear records of source system, transformation logic, and downstream use.
What good governance looks like in practice
The best governance teams don't try to standardize everything at once. They prioritize the domains that drive risk or business value first.
For example, if the near-term goal is medication reconciliation and care coordination, the governance work should start with medication data, patient identity, allergy representation, and encounter linkage. If the goal is Snowflake-based quality analytics, encounter definitions, diagnosis coding consistency, and source lineage often become first-order concerns.
Leadership question: Which data domains must be trusted first for the next strategic use case to work?
That question keeps governance from becoming abstract. It ties stewardship work to measurable enterprise outcomes.
Governance is what unlocks secondary use
Without governance, every analytics or AI team ends up rebuilding the same cleaning logic. They create parallel mappings, local exclusions, and competing definitions of the truth. That raises cost, slows delivery, and increases the risk that two executives see different numbers from the same patient population.
With governance, interoperable electronic health records become a reusable asset. Data can support care operations today and secondary use tomorrow, including quality reporting, automation, forecasting, and governed machine learning in platforms like Snowflake.
Measuring Success and Mitigating Common Pitfalls
A live interface is not a success metric. Neither is a compliance attestation. Leaders need a way to decide whether interoperability is improving care and operations or just increasing the amount of data everyone has to manage.
The evidence is encouraging, but it's not one-sided. A systematic review found that interoperability was associated with reduced patient safety events, fewer medication safety or reconciliation problems, and lower data-entry error risk, while also noting a trade-off. One included study found that task completion time increased after implementation. The review is summarized in this PubMed Central article on interoperable EHR impacts.
Measure outcomes, not interface counts
The right KPI set depends on the use case. A CTO should insist that each interoperability investment has a small group of outcome measures attached to it.
Good examples include:
- Medication reconciliation quality: Are clinicians resolving medication discrepancies with less manual work and fewer safety issues?
- Duplicate work reduction: Are repeated tests, repeated intake steps, or repeated chart abstraction tasks declining?
- Data availability for analytics: How quickly does usable data reach the governed analytical environment?
- Support burden: Are clinicians and operational teams opening fewer tickets related to missing, duplicated, or confusing data?
These are better than vanity measures because they reflect real operating impact.
The most common failure modes
Interoperability programs tend to stumble for the same reasons.
- More data, worse workflow
- Teams expose additional information but don't redesign the screen, alert logic, or reconciliation workflow. Clinicians receive more context and more clicks.
- Underestimated mapping effort
- Integration plans often budget for APIs and interfaces but not enough for terminology mapping, source profiling, exception handling, and validation.
- Compliance mistaken for usability
- Data can be technically available and still be too messy, delayed, or poorly presented to improve care.
A practical countermeasure is to test workflows as seriously as the transport layer. That includes scenario-based validation with real clinical users, not just interface analysts.
Organizations also need reliable QA around integration-heavy systems. Testing approaches used in adjacent healthcare software work can be instructive, especially when interoperability affects high-volume operational flows, as shown in this healthcare test automation example.
Interoperability should remove manual judgment from routine tasks. If it adds manual judgment, the design needs work.
A Phased Roadmap for Enterprise Implementation
Most interoperability programs fail when they try to modernize everything at once. The better path is phased, tied to business priorities, and structured so each phase leaves behind reusable assets.
A board or executive committee doesn't need a technical sprint plan. It needs a sequence that shows where value appears, how risk is managed, and what capabilities compound over time.
Phase one starts with business-critical use cases
Begin with assessment and prioritization. Map the current EHR environment, interfaces, API capabilities, governance maturity, and top pain points. Then choose a small number of use cases that matter to both clinical and operational leaders.
Good candidates usually have three traits. They affect a visible workflow, they involve cross-system data, and they can be measured without heroic effort.
Examples include:
- Care transitions: ED to inpatient, inpatient to ambulatory, or hospital to post-acute handoff
- Medication workflows: Reconciliation, discharge review, or external medication history
- Patient access: App-based retrieval of records, notes, or messaging-linked data
- Enterprise analytics feeds: Normalized clinical data into a governed Snowflake environment
Pilot for learning, not just proof
The pilot phase should be narrow enough to control risk and broad enough to test the full operating model. That means including security, privacy, data stewardship, support, and end-user validation from the start.
A useful pilot asks questions like:
- Can we resolve identity reliably across the participating systems?
- Which fields arrive but still need local interpretation?
- Where does the workflow slow down after data becomes available?
- What should land in the operational system versus the analytical platform?
At this point, many teams discover the difference between passing data and using it.
Scale what works and formalize governance
Once a pilot proves value, scale patterns, not one-off interfaces. Reuse API designs, terminology mappings, consent workflows, lineage practices, and validation methods. Formalize stewardship for the data domains that now support multiple use cases.
This phase is also where Snowflake often becomes more valuable. As more interoperable data flows into a governed platform, teams can support quality analytics, population views, automation triggers, and AI initiatives without repeating integration work for every department.
Optimize for automation and new data products
The final phase is where strategy pays off. With interoperable electronic health records feeding trusted enterprise data, organizations can build automation and analytics that were difficult in a fragmented environment. That includes care management rules, operational forecasting, patient-facing services, and governed AI workflows.
The key is discipline. Expand only after each earlier phase leaves behind reusable architecture, stronger governance, and evidence that the workflow improved rather than degraded.
Interoperable electronic health records are no longer just an IT modernization item. They're the foundation for safer care, lower operational friction, stronger patient access, and a credible healthcare data platform.
If your organization is building that foundation and needs a partner for Snowflake-centered analytics, automation, or enterprise healthcare engineering, Faberwork LLC can help design and deliver the next phase.
